458 related articles for article (PubMed ID: 24330893)
1. Randomized placebo-controlled adjunctive study of an extract of withania somnifera for cognitive dysfunction in bipolar disorder.
Chengappa KN; Bowie CR; Schlicht PJ; Fleet D; Brar JS; Jindal R
J Clin Psychiatry; 2013 Nov; 74(11):1076-83. PubMed ID: 24330893
[TBL] [Abstract][Full Text] [Related]
2. Adjunctive Use of a Standardized Extract of Withania somnifera (Ashwagandha) to Treat Symptom Exacerbation in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study.
Chengappa KNR; Brar JS; Gannon JM; Schlicht PJ
J Clin Psychiatry; 2018 Jul; 79(5):. PubMed ID: 29995356
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial.
Miskowiak KW; Ehrenreich H; Christensen EM; Kessing LV; Vinberg M
J Clin Psychiatry; 2014 Dec; 75(12):1347-55. PubMed ID: 25099079
[TBL] [Abstract][Full Text] [Related]
4. Neurocognitive functioning in patients with bipolar I disorder recently recovered from a first manic episode.
Torres IJ; DeFreitas VG; DeFreitas CM; Kauer-Sant'Anna M; Bond DJ; Honer WG; Lam RW; Yatham LN
J Clin Psychiatry; 2010 Sep; 71(9):1234-42. PubMed ID: 20361907
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychological profile in bipolar disorder: a preliminary study of monotherapy lithium-treated euthymic bipolar patients evaluated at a 2-year interval.
Mur M; Portella MJ; Martínez-Arán A; Pifarré J; Vieta E
Acta Psychiatr Scand; 2008 Nov; 118(5):373-81. PubMed ID: 18759809
[TBL] [Abstract][Full Text] [Related]
6. Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction.
Burdick KE; Braga RJ; Nnadi CU; Shaya Y; Stearns WH; Malhotra AK
J Clin Psychiatry; 2012 Jan; 73(1):103-12. PubMed ID: 22152405
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder.
McIntyre RS; Soczynska JK; Woldeyohannes HO; Miranda A; Vaccarino A; Macqueen G; Lewis GF; Kennedy SH
Bipolar Disord; 2012 Nov; 14(7):697-706. PubMed ID: 23107220
[TBL] [Abstract][Full Text] [Related]
8. The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies.
Zhang ZJ; Kang WH; Li Q; Tan QR
J Psychiatr Res; 2007 Nov; 41(10):828-36. PubMed ID: 17010995
[TBL] [Abstract][Full Text] [Related]
9. Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients.
Mur M; Portella MJ; Martínez-Arán A; Pifarré J; Vieta E
J Clin Psychiatry; 2008 May; 69(5):712-9. PubMed ID: 18435565
[TBL] [Abstract][Full Text] [Related]
10. Supraphysiologic doses of levothyroxine as adjunctive therapy in bipolar depression: a randomized, double-blind, placebo-controlled study.
Stamm TJ; Lewitzka U; Sauer C; Pilhatsch M; Smolka MN; Koeberle U; Adli M; Ricken R; Scherk H; Frye MA; Juckel G; Assion HJ; Gitlin M; Whybrow PC; Bauer M
J Clin Psychiatry; 2014 Feb; 75(2):162-8. PubMed ID: 24345793
[TBL] [Abstract][Full Text] [Related]
11. Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial.
Bowden CL; Vieta E; Ice KS; Schwartz JH; Wang PP; Versavel M
J Clin Psychiatry; 2010 Feb; 71(2):130-7. PubMed ID: 20122373
[TBL] [Abstract][Full Text] [Related]
12. Executive function and attention span in euthymic patients with bipolar 1 disorder.
Normala I; Abdul HA; Azlin B; Nik Ruzyanei NJ; Hazli Z; Shah SA
Med J Malaysia; 2010 Sep; 65(3):199-203. PubMed ID: 21939168
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently.
Macfadden W; Alphs L; Haskins JT; Turner N; Turkoz I; Bossie C; Kujawa M; Mahmoud R
Bipolar Disord; 2009 Dec; 11(8):827-39. PubMed ID: 19922552
[TBL] [Abstract][Full Text] [Related]
14. Cognitive functioning in euthymic bipolar I and bipolar II patients.
Dittmann S; Hennig-Fast K; Gerber S; Seemüller F; Riedel M; Emanuel Severus W; Langosch J; Engel RR; Möller HJ; Grunze HC
Bipolar Disord; 2008 Dec; 10(8):877-87. PubMed ID: 19594503
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of cognitive impairment in bipolar disorder.
Torrent C; Martinez-Arán A; del Mar Bonnin C; Reinares M; Daban C; Solé B; Rosa AR; Tabarés-Seisdedos R; Popovic D; Salamero M; Vieta E
J Clin Psychiatry; 2012 Jul; 73(7):e899-905. PubMed ID: 22901360
[TBL] [Abstract][Full Text] [Related]
16. Comparison of neuropsychological effects of adjunctive risperidone or quetiapine in euthymic patients with bipolar I disorder.
Kozicky JM; Torres IJ; Bond DJ; Lam RW; Yatham LN
Int Clin Psychopharmacol; 2012 Mar; 27(2):91-9. PubMed ID: 22124206
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
Sachs GS; Ice KS; Chappell PB; Schwartz JH; Gurtovaya O; Vanderburg DG; Kasuba B
J Clin Psychiatry; 2011 Oct; 72(10):1413-22. PubMed ID: 21672493
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for cognitive impairment in elderly bipolar patients.
Schouws SN; Stek ML; Comijs HC; Beekman AT
J Affect Disord; 2010 Sep; 125(1-3):330-5. PubMed ID: 20079932
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).
Young AH; McElroy SL; Bauer M; Philips N; Chang W; Olausson B; Paulsson B; Brecher M;
J Clin Psychiatry; 2010 Feb; 71(2):150-62. PubMed ID: 20122369
[TBL] [Abstract][Full Text] [Related]
20. The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter study.
Hanagasi HA; Gurvit H; Unsalan P; Horozoglu H; Tuncer N; Feyzioglu A; Gunal DI; Yener GG; Cakmur R; Sahin HA; Emre M
Mov Disord; 2011 Aug; 26(10):1851-8. PubMed ID: 21500280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
